PARPInhibitorslatissimusflapNeoplasmAdvocacyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.IntraductalPapillomaEGFR(epidermalgrowth factorreceptor)FlowCytometryMorpheaLymphoscintigraphyCo-survivorHER-21 in 8womenBenignPhyllodesTumorHerceptinEstrogenStagingAntibodyTherapyCyclophosphamideEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearLapatinibBOCAER-5-FluorouracilFamilyHistoryNodeNegativeSclerosingAdenosisMetastasisMastodyniaRelapseLumpNeoadjuvantTherapyCystBevacizumabAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55MolecularBreastImagingGenomicTestingDefinitiveSurgeryLCISDisease-FreeSurvivalRateAdjuvantTherapyBreastCancerPrecisionMedicineCMFChemotherapyLymphNodeStatusDocetaxelCDK4/6InhibitorsMultifocalTumorsApoptosisPI3KinaseInhibitorsTyrosine-KinaseInhibitorHormoneReplacementTherapyTripleNegativeBreastCancerER+MastectomyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCheckpointInhibitorNodePositiveFibroadenomaWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.FISHAlopeciaPathologicResponsePalpationKi-67RateProgestinMultimodalityTherapyEvidencesuggests thatphysical activitymay reduce therisk of breastcancersmTORInhibitorsSelf-examinationMethotrexateEstradiolBRCAGeneGeneticCounselingECOGScoreAngiogenesisAyurvedaInvasiveBreastCancerCalcificationsLumpectomyRaloxifeneDiabeticMastopathyDoseDenseTherapyGermlineMutationCapecitabineKappaEpsilonPalbociclibLiquidBiopsySERMRADCytotoxicBrachytherapyMegestrolAcetateHormoneReceptorStatusTamoxifenOophorectomyGeneMutationBilateralProphylacticMastectomyEndometrialCancerOvarianSuppressionPhyllodesTumorPaclitaxelCAMACChemotherapyDown-StagingMastalgiaAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenAdenocarcinomaChemopreventionDoxorubicinGailModelExcisionalBiopsyCytostaticMRIAromataseInhibitorsBreastTomosynthesisOligometastasesTriplePositiveBreastCancerTumorGradeMetastaticBreastCancerWomen ages40+ shouldhave a clinicalbreast examat least yearlyBiopsyBI-RADSMastitisGeneticPredispositionAntiemeticChemotherapyIn-situCarcinomaAxillarySamplingRadiotherapyDimplingAnastrozoleCachexiaImmunotherapyGuaranteedRenewableInsuranceAbsoluteRiskPagetDiseasePARPInhibitorslatissimusflapNeoplasmAdvocacyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.IntraductalPapillomaEGFR(epidermalgrowth factorreceptor)FlowCytometryMorpheaLymphoscintigraphyCo-survivorHER-21 in 8womenBenignPhyllodesTumorHerceptinEstrogenStagingAntibodyTherapyCyclophosphamideEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearLapatinibBOCAER-5-FluorouracilFamilyHistoryNodeNegativeSclerosingAdenosisMetastasisMastodyniaRelapseLumpNeoadjuvantTherapyCystBevacizumabAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55MolecularBreastImagingGenomicTestingDefinitiveSurgeryLCISDisease-FreeSurvivalRateAdjuvantTherapyBreastCancerPrecisionMedicineCMFChemotherapyLymphNodeStatusDocetaxelCDK4/6InhibitorsMultifocalTumorsApoptosisPI3KinaseInhibitorsTyrosine-KinaseInhibitorHormoneReplacementTherapyTripleNegativeBreastCancerER+MastectomyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCheckpointInhibitorNodePositiveFibroadenomaWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.FISHAlopeciaPathologicResponsePalpationKi-67RateProgestinMultimodalityTherapyEvidencesuggests thatphysical activitymay reduce therisk of breastcancersmTORInhibitorsSelf-examinationMethotrexateEstradiolBRCAGeneGeneticCounselingECOGScoreAngiogenesisAyurvedaInvasiveBreastCancerCalcificationsLumpectomyRaloxifeneDiabeticMastopathyDoseDenseTherapyGermlineMutationCapecitabineKappaEpsilonPalbociclibLiquidBiopsySERMRADCytotoxicBrachytherapyMegestrolAcetateHormoneReceptorStatusTamoxifenOophorectomyGeneMutationBilateralProphylacticMastectomyEndometrialCancerOvarianSuppressionPhyllodesTumorPaclitaxelCAMACChemotherapyDown-StagingMastalgiaAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenAdenocarcinomaChemopreventionDoxorubicinGailModelExcisionalBiopsyCytostaticMRIAromataseInhibitorsBreastTomosynthesisOligometastasesTriplePositiveBreastCancerTumorGradeMetastaticBreastCancerWomen ages40+ shouldhave a clinicalbreast examat least yearlyBiopsyBI-RADSMastitisGeneticPredispositionAntiemeticChemotherapyIn-situCarcinomaAxillarySamplingRadiotherapyDimplingAnastrozoleCachexiaImmunotherapyGuaranteedRenewableInsuranceAbsoluteRiskPagetDisease

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. PARP Inhibitors
  2. latissimus flap
  3. Neoplasm
  4. Advocacy
  5. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  6. Intraductal Papilloma
  7. EGFR (epidermal growth factor receptor)
  8. Flow Cytometry
  9. Morphea
  10. Lymphoscintigraphy
  11. Co-survivor
  12. HER-2
  13. 1 in 8 women
  14. Benign Phyllodes Tumor
  15. Herceptin
  16. Estrogen
  17. Staging
  18. Antibody Therapy
  19. Cyclophosphamide
  20. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  21. Lapatinib
  22. BOCA
  23. ER-
  24. 5-Fluorouracil
  25. Family History
  26. Node Negative
  27. Sclerosing Adenosis
  28. Metastasis
  29. Mastodynia
  30. Relapse
  31. Lump
  32. Neoadjuvant Therapy
  33. Cyst
  34. Bevacizumab
  35. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  36. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  37. Molecular Breast Imaging
  38. Genomic Testing
  39. Definitive Surgery
  40. LCIS
  41. Disease-Free Survival Rate
  42. Adjuvant Therapy
  43. Breast Cancer
  44. Precision Medicine
  45. CMF Chemotherapy
  46. Lymph Node Status
  47. Docetaxel
  48. CDK4/6 Inhibitors
  49. Multifocal Tumors
  50. Apoptosis
  51. PI3 Kinase Inhibitors
  52. Tyrosine-Kinase Inhibitor
  53. Hormone Replacement Therapy
  54. Triple Negative Breast Cancer
  55. ER+
  56. Mastectomy
  57. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  58. Checkpoint Inhibitor
  59. Node Positive
  60. Fibroadenoma
  61. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  62. FISH
  63. Alopecia
  64. Pathologic Response
  65. Palpation
  66. Ki-67 Rate
  67. Progestin
  68. Multimodality Therapy
  69. Evidence suggests that physical activity may reduce the risk of breast cancers
  70. mTOR Inhibitors
  71. Self-examination
  72. Methotrexate
  73. Estradiol
  74. BRCA Gene
  75. Genetic Counseling
  76. ECOG Score
  77. Angiogenesis
  78. Ayurveda
  79. Invasive Breast Cancer
  80. Calcifications
  81. Lumpectomy
  82. Raloxifene
  83. Diabetic Mastopathy
  84. Dose Dense Therapy
  85. Germline Mutation
  86. Capecitabine
  87. Kappa Epsilon
  88. Palbociclib
  89. Liquid Biopsy
  90. SERM
  91. RAD
  92. Cytotoxic
  93. Brachytherapy
  94. Megestrol Acetate
  95. Hormone Receptor Status
  96. Tamoxifen
  97. Oophorectomy
  98. Gene Mutation
  99. Bilateral Prophylactic Mastectomy
  100. Endometrial Cancer
  101. Ovarian Suppression
  102. Phyllodes Tumor
  103. Paclitaxel
  104. CAM
  105. AC Chemotherapy
  106. Down-Staging
  107. Mastalgia
  108. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  109. Adenocarcinoma
  110. Chemoprevention
  111. Doxorubicin
  112. Gail Model
  113. Excisional Biopsy
  114. Cytostatic
  115. MRI
  116. Aromatase Inhibitors
  117. Breast Tomosynthesis
  118. Oligometastases
  119. Triple Positive Breast Cancer
  120. Tumor Grade
  121. Metastatic Breast Cancer
  122. Women ages 40+ should have a clinical breast exam at least yearly
  123. Biopsy
  124. BI-RADS
  125. Mastitis
  126. Genetic Predisposition
  127. Antiemetic
  128. Chemotherapy
  129. In-situ Carcinoma
  130. Axillary Sampling
  131. Radiotherapy
  132. Dimpling
  133. Anastrozole
  134. Cachexia
  135. Immunotherapy
  136. Guaranteed Renewable Insurance
  137. Absolute Risk
  138. Paget Disease